Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
ASCO Foundation Raised $200,000 In Its First Year.
ASCO Selects Three Cities For Quality Of Care Study.
Early Detection Network Completes Initial Funding From NCI.
FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.
Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.
One Health Plan, Genzyme Agree On Genetic Testing.
ECOG To Cease Participation In Melanoma Vaccine Study.
Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.
Myriad Wins Patent For p10 Tumor Suppressor Gene.
Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?
- Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem
- NIH agrees to review hundreds of denied or shelved grant applications
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”









